Navidea Biopharmaceuticals, Inc. (NAVB)

NAVB Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	3.86	2	4.23	2.67	1.05	3.48
Short-Term Investments	-	-	-	-	-	0.8
Cash & Short-Term Investments	3.86	2	4.23	2.67	1.05	4.28
Cash Growth	-16.00%	-52.83%	58.43%	155.02%	-75.51%	-6.91%
Accounts Receivable	-	0	0.09	0.06	0.08	0.02
Other Receivables	0.03	0	0	2.93	1.13	0.6
Receivables	0.03	0	0.09	2.99	1.21	0.62
Inventory	0.46	0.43	0.15	0.17	-	-
Prepaid Expenses	0.15	0.78	0.91	0.7	0.66	0.7
Total Current Assets	4.5	3.2	5.38	6.53	2.92	5.6
Property, Plant & Equipment	0.12	0.16	0.25	0.38	0.31	0.16
Other Intangible Assets	1.06	1	0.79	0.62	0.39	0.43
Other Long-Term Assets	0.01	0.01	0.23	0.23	0.54	0.84
Total Assets	5.7	4.37	6.64	7.76	4.15	7.02
Accounts Payable	2.07	2.12	1.42	1.16	1.11	0.42
Accrued Expenses	3.39	6.46	3.11	2.48	2.14	2.5
Current Portion of Long-Term Debt	1.25	0.54	0.45	0.75	0.31	0.32
Current Portion of Leases	0.01	0.02	0.28	0.29	0.25	-
Current Unearned Revenue	0.8	0.8	0.04	-	-	-
Other Current Liabilities	0.46	0	-	0.03	0.01	0.13
Total Current Liabilities	7.98	9.94	5.3	4.72	3.82	3.38
Long-Term Debt	-	1.87	-	-	-	-
Long-Term Leases	0	0	0.02	0.3	0.51	-
Long-Term Unearned Revenue	0.7	0.7	0.7	0.7	0.7	0.7
Other Long-Term Liabilities	-	-	-	-	-	0.53
Total Liabilities	8.68	12.51	6.02	5.71	5.03	4.61
Common Stock	0.29	0.22	0.22	0.22	0.21	0.2
Additional Paid-In Capital	382.35	379.34	370.46	375.43	345.85	338.27
Retained Earnings	-385.91	-388	-370.79	-359.06	-347.67	-336.72
Comprehensive Income & Other	-	-	-	-4.97	0	-0
Total Common Equity	-3.27	-8.44	-0.11	11.62	-1.61	1.74
Minority Interest	0.29	0.29	0.73	0.73	0.73	0.67
Shareholders' Equity	-2.98	-8.14	0.62	2.05	-0.88	2.41
Total Liabilities & Equity	5.7	4.37	6.64	7.76	4.15	7.02
Total Debt	1.26	2.44	0.75	1.34	1.07	0.32
Net Cash (Debt)	2.61	-0.44	3.48	1.33	-0.02	3.96
Net Cash Growth	-6.32%	-	160.96%	-	-	76.83%
Net Cash Per Share	0.05	-0.01	0.12	0.06	-0.00	0.46
Filing Date Shares Outstanding	99.99	32.76	30.2	28.51	20.42	10.03
Total Common Shares Outstanding	99.99	32.6	30.18	27.09	19.22	10.01
Working Capital	-3.48	-6.74	0.08	1.81	-0.9	2.22
Book Value Per Share	-0.03	-0.26	-0.00	0.43	-0.08	0.17
Tangible Book Value	-4.34	-9.44	-0.89	11	-2	1.31
Tangible Book Value Per Share	-0.04	-0.29	-0.03	0.41	-0.10	0.13
Machinery	-	0.49	0.52	0.51	0.87	0.9
Leasehold Improvements	-	0.02	0.02	0.01	0.01	0.01

Source: S&P Capital IQ. Standard template. Financial Sources.